characteristics of betanin-encapsulated chitosan nanoparticles (ChBetNPs)
Category
Nano-inhibitors
EC50
IC50
0.5255 μg/mL vs
Inhibition
Toxicity
ROS(reactive oxygen species)
Metal Chelating
BBB(blood-brain barrier)
Target Protein
Acetylcholinesterase (AChE)
Effects
(1) ChBetNPs was shown to exhibit strong antioxidant, anti-inflammatory and anti-acetylcholinesterase activities thus making it a significant therapeutic agent for the management of Alzheimer's disease.
